Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02790463 · ClinicalTrials.gov registry record · NA

Virtual Gout Clinic

A NA study of Gout, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
1,463
Enrollment target
2
Study locations

NCT02790463 is a NA study of Gout that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,463 participants, below the 8,845-participant average among 34 other Gout trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02790463, a NA study of Gout, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
1,463 participants
Enrollment target
2
Study locations

Study Summary

The overarching goal of the investigators project is to identify best practices in gout and hyperuricemia management, translate these evidence-based practices into a highly generalizable strategy for optimal delivery of gout care, and implement and evaluate such a strategy in a large, population-based healthcare setting. With the use of novel but readily-accessible technology, the investigators will examine the use of a novel, large-scale, and relatively low-cost pharmacy-based intervention, with the goal of optimizing urate lower therapy (ULT) in chronic gout treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Pharmacist-Led Intervention

Study Locations (2)

Alabama

  • University of Alabama at Birmingham - Birmingham

California

  • Kaiser Permanente - Pasadena

Trial Details

FieldValue
Enrollment Target 1,463 participants
Start Date 2013-01
Est. Completion 2018-10
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02790463

The ClinicalTrials.gov registry entry for NCT02790463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,463 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,845-participant average among 34 other Gout trials with a reported enrollment target (83% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gout appearing as the primary indexed condition, and to 1 intervention - of which Pharmacist-Led Intervention is the first listed.

NCT02790463 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, California.

Frequently Asked Questions

What is clinical trial NCT02790463 about?

NCT02790463 is a clinical study titled "Virtual Gout Clinic". The overarching goal of the investigators project is to identify best practices in gout and hyperuricemia management, translate these evidence-based practices into a highly generalizable strategy for optimal delivery of gout care, and implement and evaluate such a strategy in a large, population-bas...

What is the current status of trial NCT02790463?

This trial is currently completed. It is a NA study. The enrollment target is 1,463 participants. The study started on 2013-01. Estimated completion is 2018-10.

What conditions does trial NCT02790463 study?

This clinical trial studies the following conditions: Gout.

What interventions are being tested in trial NCT02790463?

The interventions under investigation include: Pharmacist-Led Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02790463?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02790463 being conducted?

This trial has 2 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gout

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.